Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -60.00% vs -51.61% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
No Fixed Assets in the last few periods;
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 50.00% vs -30.77% in Mar 2024
Compare Balance Sheet Results of Omkar Pharmachem
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
10.08
9.81
0.27
2.75%
Share Warrants & Outstandings
Total Reserve
-0.65
-3.75
3.10
82.67%
Shareholder's Funds
9.43
6.06
3.37
55.61%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.00
0.00
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-0.03
0.00
-0.03
0.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
-0.03
0.00
-0.03
0.00%
Current Liabilities
Trade Payables
0.01
0.00
0.01
0.00%
Other Current Liabilities
0.04
0.03
0.01
33.33%
Short Term Borrowings
0.12
0.00
0.12
0.00%
Short Term Provisions
0.00
0.00
0.00
0.00%
Total Current Liabilities
0.17
0.03
0.14
466.67%
Total Liabilities
9.57
6.08
3.49
57.40%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
0.03
0.00
0.03
0.00%
Less: Accumulated Depreciation
0.03
0.00
0.03
0.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.01
0.00
0.01
0.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
9.30
0.65
8.65
1,330.77%
Long Term Loans & Advances
0.00
0.00
0.00
0.00%
Other Non Current Assets
0.00
0.11
-0.11
-100.00%
Total Non-Current Assets
9.31
0.76
8.55
1,125.00%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
0.00
0.00
0.00
0.00%
Sundry Debtors
0.10
0.00
0.10
0.00%
Cash and Bank
0.11
1.94
-1.83
-94.33%
Other Current Assets
0.06
0.03
0.03
100.00%
Short Term Loans and Advances
0.00
3.36
-3.36
-100.00%
Total Current Assets
0.27
5.32
-5.05
-94.92%
Net Current Assets (Including Current Investments)
0.10
5.29
-5.19
-98.11%
Total Current Assets Excluding Current Investments
0.27
5.32
-5.05
-94.92%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
9.57
6.08
3.49
57.40%
Contingent Liabilities
0.00
0.28
-0.28
-100.00%
Total Debt
0.12
0.00
0.12
0.00%
Book Value per share (adjusted)
9.36
3.09
6.27
202.91%
Annual - Borrowings
Borrowings 0.12 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -60.00% vs -51.61% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 0.01 Cr
in Mar 2025Figures in Cr
No Fixed Assets in the last few periods;
Annual - Investments
Investments 9.30 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 0.27 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 50.00% vs -30.77% in Mar 2024






